News About: Pharm. Industry
Court ruling paves way to dismiss public distrust over drug makers
The Seoul High Court has invalidated an administrative disposition the health regulator imposed in 2009 on a pharmaceutical firm for selling medicines containing talc contaminated with asbestos.
The ruling paves wa...
Hanmi, Korea United seeking new growth engines
Pharmaceutical companies here are scrambling to find new growth engines against a deteriorating business environment in the aftermath of the government’s forced price cut for drugs covered by National Health Insurance...
Dong-A’s novel antibacterial agent receives positive results from Phase 3 clinical trial in severe s
Trius Therapeutics, Inc. on March 25 announced top-line results from its ESTABLISH 2 Phase 3 clinical trial of tedizolid phosphate (DA-7218) for the treatment of acute bacterial skin and skin structure infections (ABS...
Simponi, Enbrel set to fuel competition in rheumatism drug market
New brand Simponi (golimumab) and Enbrel (etanercept 50 mg) prefilled syringe are expected to rev up the domestic rheumatism drug market, which is valued at 85 billion won.
So far, three products, such as Janssen’s...
Korea Pharm 2013 to open
Domestic pharmaceutical firms and foreign buyers will gather in Korea in May for an international meeting on pharmaceutical ingredients.
The Korea Pharm 2013 (Korea International Pharmaceutical Ingredient Exhibitio...
Daewoong Pharmaceutical names Chung J.G new vice presidentDaewoong Pharmaceutical promoted its OTC business division head Chung Jong-geun to lead its holding company Daewoong in the group’s latest executive reshuffle Monday.
Along w...
|
Government step up crackdown on rebate practices in medical industry
A heavier punishments over kickbacks, or rebates will be imposed starting April in a move aimed at enhancing overall transparency in the medical industry.
Under the revised guideline, the sales ban period of drugs ...
Pharmaceutical firms sitting on huge cash pile
Korean drug makers remain reluctant to invest. Instead, they are choosing to hold record amounts of cash reserves against the continued uncertain economic outlook and government’s drug related policies, which analysts...
Drug makers face bumpy road
Korea’s drug companies are facing a bumpy road ahead as a consequence of the government’s push to slash drug prices last April.
“The future growth of the domestic pharmaceutical industry is unclear because of drama...
Lee Moon-suk to spearhead SK Green Chemical BizSK Chemicals, Korea’s leading pharmaceutical and chemical products manufacturer, said last Friday that the firm has nominated Lee Moon-suk as its new joint CEO after meetings of...
|
